These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 33323276)

  • 1. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
    Johnson NL; Head KJ; Scott SF; Zimet GD
    Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Cancer Screening Among Homeless Women of New York City Shelters.
    Asgary R; Alcabes A; Feldman R; Garland V; Naderi R; Ogedegbe G; Sckell B
    Matern Child Health J; 2016 Jun; 20(6):1143-50. PubMed ID: 26649876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical testing beyond the screening target age - A register-based cohort study from Finland.
    Keltto N; Leivonen A; Pankakoski M; Sarkeala T; Heinävaara S; Anttila A
    Gynecol Oncol; 2021 Aug; 162(2):315-321. PubMed ID: 34074539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Mills JM; Morgan JR; Dhaliwal A; Perkins RB
    Gynecol Oncol; 2021 Aug; 162(2):308-314. PubMed ID: 34090706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
    Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
    J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual, provider, and system risk factors for breast and cervical cancer screening among underserved Black, Latina, and Arab women.
    Roman L; Meghea C; Ford S; Penner L; Hamade H; Estes T; Williams KP
    J Womens Health (Larchmt); 2014 Jan; 23(1):57-64. PubMed ID: 24283674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
    Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
    Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among young adult women in the United States.
    Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Is Health Literacy Related to Pap Testing Among US Women?
    Thompson EL; Wheldon CW; Vamos CA; Griner SB; Daley EM
    J Cancer Educ; 2019 Aug; 34(4):789-795. PubMed ID: 29931455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States.
    Wee CC; Phillips RS; McCarthy EP
    Obes Res; 2005 Jul; 13(7):1275-80. PubMed ID: 16076999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.
    Hirth JM; Laz TH; Rahman M; Berenson AB
    J Womens Health (Larchmt); 2016 Apr; 25(4):371-80. PubMed ID: 26579735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.